Q&A: Naloxone is not enough
EMS1 article by Mike Taigman and Silvia Verdugo MD, MPH, where Medical Director and Emergency Physician Gene Hern explores the potential for treating patients with opioid use disorder with buprenorphine.
Related Posts
01Dec
Secure in the Cloud:The New Public vs. Private Debate is in Data Security
Download PDF (Journal of Emergency Medical Services, JEMS, December 2012) In this article from the December 2012 edition of... read more
02Sep
FirstWatch and National EMS Quality Alliance Form New Partnership – JEMS
FirstWatch, a technology and quality improvement company that supports public safety and healthcare organizations, has joined forces with the... read more
02Apr
County Launches ‘Smoke Detector’ for Bioterror
Download PDF (The Wichita Eagle, April 2004) read more
12May
New EMS1 Column Post by Mike Taigman – How to deal with angry EMS employees
Read the latest post in the new Paramedic Chief column via EMS1, "Better EMS Performance" led by our own... read more
20Sep
Pinnacle Webinar Series: Fighting the Opioid Crisis with EMS Data
Join us October 5 at 1 p.m. ET (10 a.m. PT) for an interactive live discussion about combating the... read more
26Sep
Richmond (Virginia) Ambulance Authority and FirstWatch Celebrate 12 Years Together
Download the PDF The industry leader in public safety data, FirstWatch® is pleased to announce the 12th anniversary of... read more
23Jul
Webinar Recording: PSO's and EMS – Center for Patient Safety
Patient Safety Organizations are becoming an integral part of the safety of our our patients and caregivers. For the... read more
17Mar
EMS1 Article – Quick Take: COVID-19 EMS Patient Management: Myth vs. Reality webinar
EMS1 article by Rob Lawrence - Communication, PPE and decontamination strategies highlighted the 4th FirstWatch and Paramedic Chiefs of... read more
02Sep
FirstWatch becomes 1st industry partner of the National EMS Quality Alliance – EMS1
The technology company will support the NEMSQA's efforts to develop, test and validate quality measures for EMS. read more
